ArticleFrontiers in pharmacology2022

Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation.

Duncan C Humphries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.